Senecioic acid

CAS No. 541-47-9

Senecioic acid( 3-Methylcrotonic Acid | 33-Dimethylacrylic Acid )

Catalog No. M19993 CAS No. 541-47-9

Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Senecioic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).
  • Description
    Senecioic acid appears in the urine of patients with 3-Methylcrotonic aciduria which is a disorder characterized by urine that contains increased amounts of 3-methylcrotonic acid (Senecioic acid).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-Methylcrotonic Acid | 33-Dimethylacrylic Acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    541-47-9
  • Formula Weight
    100.12
  • Molecular Formula
    C5H8O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:200 mM
  • SMILES
    C\C(C)=C\C(O)=O
  • Chemical Name
    2-Butenoic acid 3-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Duran M et al. Organic acid excretion in a patient with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: facts and artefacts. Clin Chim Acta. 1978 Dec 1;90(2):187-93.
molnova catalog
related products
  • C2 Ceramide

    A potent modulator of cell proliferation and differentiation.

  • ARA-290

    ARA290 is a nonerythropoietic peptide engineered from erythropoietin,, and used for neurological disease treatment.

  • Marmesin b

    Marmesin is a novel angiogenesis inhibitor.